Sigma Planning Corp’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-8,194
Closed -$260K – 762
2015
Q4
$260K Sell
8,194
-470
-5% -$14.4K 0.04% 504
2015
Q3
$242K Buy
+8,664
New +$302K 0.04% 505

Other funds holding SBIO

Sigma Planning Corp's SBIO Position: Q1 2016 in Review

Sigma Planning Corp sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2016, closing a stake of 8,194 shares — an estimated $260K sold.

Sigma Planning Corp first reported a position in SBIO in Q3 2015 and held it in 2 quarters. The position peaked at $260K in Q4 2015. 23 funds tracked by Wall St. Rank hold SBIO as of Q1 2016.

  • Sigma Planning Corp reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2016 after selling out during the quarter.
  • Sigma Planning Corp sold 8,194 ALPS Medical Breakthroughs ETF shares in Q1 2016, an estimated $260K.
  • Sigma Planning Corp first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and held it in 2 quarters.
  • Sigma Planning Corp's ALPS Medical Breakthroughs ETF position peaked at $260K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2016.

Based on Sigma Planning Corp's 13F filing for Q1 2016, filed 18 Apr 2016.